Van Nest G - Search Results

1

Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity.

Andrews CD, Huh MS, Patton K, Higgins D, Van Nest G, Ott G, Lee KD. Andrews CD, et al. Among authors: van nest g. Mol Pharm. 2012 May 7;9(5):1118-25. doi: 10.1021/mp2003835. Epub 2012 Apr 6. Mol Pharm. 2012. PMID: 22376145 Free PMC article.

2

A minimal human immunostimulatory CpG motif that potently induces IFN-gamma and IFN-alpha production.

Fearon K, Marshall JD, Abbate C, Subramanian S, Yee P, Gregorio J, Teshima G, Ott G, Tuck S, Van Nest G, Coffman RL. Fearon K, et al. Among authors: van nest g. Eur J Immunol. 2003 Aug;33(8):2114-22. doi: 10.1002/eji.200323948. Eur J Immunol. 2003. PMID: 12884285 Free article.

3

Polymyxin B enhances ISS-mediated immune responses across multiple species.

Marshall JD, Higgins D, Abbate C, Yee P, Teshima G, Ott G, dela Cruz T, Passmore D, Fearon KL, Tuck S, Van Nest G. Marshall JD, et al. Among authors: van nest g. Cell Immunol. 2004 Jun;229(2):93-105. doi: 10.1016/j.cellimm.2004.04.009. Cell Immunol. 2004. PMID: 15474524

4

Immunostimulatory DNA as a vaccine adjuvant.

Higgins D, Marshall JD, Traquina P, Van Nest G, Livingston BD. Higgins D, et al. Among authors: van nest g. Expert Rev Vaccines. 2007 Oct;6(5):747-59. doi: 10.1586/14760584.6.5.747. Expert Rev Vaccines. 2007. PMID: 17931155 Free article. Review.

5

Modulation of immunogenicity and allergenicity by controlling the number of immunostimulatory oligonucleotides linked to Amb a 1.

Higgins D, Rodriguez R, Milley R, Marshall J, Abbate C, dela Cruz T, Patton K, Walker F, Chichester K, Eiden J, Tuck S, Van Nest G. Higgins D, et al. Among authors: van nest g. J Allergy Clin Immunol. 2006 Aug;118(2):504-10. doi: 10.1016/j.jaci.2006.05.001. Epub 2006 Jun 27. J Allergy Clin Immunol. 2006. PMID: 16890778

6

Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.

Pyles RB, Higgins D, Chalk C, Zalar A, Eiden J, Brown C, Van Nest G, Stanberry LR. Pyles RB, et al. Among authors: van nest g. J Virol. 2002 Nov;76(22):11387-96. doi: 10.1128/jvi.76.22.11387-11396.2002. J Virol. 2002. PMID: 12388699 Free PMC article.

7

Evolving strategies for the prevention of influenza infection: potential for multistrain targeting.

Livingston BD, Higgins D, Van Nest G. Livingston BD, et al. Among authors: van nest g. BioDrugs. 2006;20(6):335-40. doi: 10.2165/00063030-200620060-00003. BioDrugs. 2006. PMID: 17176120

8

Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles.

O'Hagan DT, Ott GS, Van Nest G. O'Hagan DT, et al. Among authors: van nest g. Mol Med Today. 1997 Feb;3(2):69-75. doi: 10.1016/S1357-4310(96)10058-7. Mol Med Today. 1997. PMID: 9060004 Review.

9

MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice.

Higgins DA, Carlson JR, Van Nest G. Higgins DA, et al. Among authors: van nest g. Vaccine. 1996 Apr;14(6):478-84. doi: 10.1016/0264-410x(95)00240-2. Vaccine. 1996. PMID: 8782343

10

Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.

Ott G, Barchfeld GL, Van Nest G. Ott G, et al. Among authors: van nest g. Vaccine. 1995 Nov;13(16):1557-62. doi: 10.1016/0264-410x(95)00089-j. Vaccine. 1995. PMID: 8578842

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters